Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Epigenetics in Drug Discovery

Ann Boriack-Sjodin's Biography

Ann Boriack-Sjodin, Senior Director, Protein & Structural Sciences, Epizyme

Ann Boriack-Sjodin joined Epizyme in 2012 and is currently a Senior Director in Lead Discovery. She has spent her industrial career using structural biology, biochemical and biophysical methods to progress drug discovery programs in a variety of therapeutic areas. Her work at Epizyme has contributed to the biochemical and structural characterization as well as the development of tool compounds for several protein methyltransferases. Prior to joining Epizyme, Ann worked at AstraZeneca where she contributed to efforts in infectious disease and oncology therapeutic areas and Biogen Idec where she contributed to both small molecule and biologic drug discovery programs. She obtained her PhD from the University of Pennsylvania in 1996 working with Dr. David Christianson and received postdoctoral training in the lab of Dr. John Kuriyan at The Rockefeller University.

Ann Boriack-Sjodin Image

Protein Methyltransferases and Drug Discovery

Monday, 6 March 2017 at 11:45

Add to Calendar ▼2017-03-06 11:45:002017-03-06 12:45:00Europe/LondonProtein Methyltransferases and Drug

Optimization of novel, potent, and selective inhibitors of SMYD3, the effects of these compounds on cancer cell lines and comparison enzymatic inhibition with gene ablation technologies.

Add to Calendar ▼2017-03-06 00:00:002017-03-07 00:00:00Europe/LondonEpigenetics in Drug